tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Echo IQ Limited Issues 2 Million Shares Following Performance Rights Exercise

Story Highlights
  • Echo IQ specializes in AI-driven technology for cardiology decision-making.
  • Echo IQ issued 2 million shares, aligning with legal compliance and strategic market positioning.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Echo IQ Limited Issues 2 Million Shares Following Performance Rights Exercise

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

EchoIQ Limited ( (AU:EIQ) ) has issued an update.

Echo IQ Limited has issued 2,000,000 fully paid ordinary shares following the exercise of vested Performance Rights, as part of its securities quoted on the Australian Securities Exchange. This issuance, conducted without disclosure to investors under specific sections of the Corporations Act 2001, signifies the company’s compliance with relevant legal provisions and reflects its strategic moves in the market.

The most recent analyst rating on (AU:EIQ) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.

More about EchoIQ Limited

Echo IQ is an AI and Medical Technology company based in Sydney, Australia, specializing in AI-driven technology and proprietary software to enhance decision-making in Cardiology.

Average Trading Volume: 1,518,527

Technical Sentiment Signal: Sell

Current Market Cap: A$116.6M

See more data about EIQ stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1